Demethylase FTO significantly promoted melanoma tumorigenesis and decreased response to anti-PD-1 blockade immunotherapy, suggesting that FTO inhibition combined with anti-PD-1 blockade may sensitize immunotherapy in melanoma (14). The gene discussed is FTO; the disease is melanoma.